venBio Select Advisor »

Apogee Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-12-31 $38M 500k 75.48

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Structure Therapeutics Sponsored Ads (GPCR)
Avidity Biosciences Common (RNA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Celcuity Common (CELC)
Apellis Pharmaceuticals Common (APLS)
Vera Therapeutics Common (VERA)
Spdr Series Trust - S&p Biotech Etf (XBI)
Xenon Pharmaceuticals Common (XENE)

View all positions for venBio Select Advisor

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Alliancebernstein
Perceptive Advisors
Affinity Asset Advisors
Citadel Advisors
Jpmorgan Chase & Co

View all funds holding Apogee Therapeutics